BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36420999)

  • 1. Fetal hemoglobin per erythrocyte (HbF/F-cell) after gene therapy for sickle cell anemia.
    Sebastiani P; Steinberg MH
    Am J Hematol; 2023 Feb; 98(2):E32-E34. PubMed ID: 36420999
    [No Abstract]   [Full Text] [Related]  

  • 2. Sickle cell anemia and fetal hemoglobin.
    Steinberg MH
    Am J Med Sci; 1994 Nov; 308(5):259-65. PubMed ID: 7526687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased HbF in sickle cell anemia is determined by a factor linked to the beta S gene from one parent.
    Milner PF; Leibfarth JD; Ford J; Barton BP; Grenett HE; Garver FA
    Blood; 1984 Jan; 63(1):64-72. PubMed ID: 6197115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.
    Habara AH; Shaikho EM; Steinberg MH
    Am J Hematol; 2017 Nov; 92(11):1233-1242. PubMed ID: 28736939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicine. Sickle cell disease at 100 years.
    Orkin SH; Higgs DR
    Science; 2010 Jul; 329(5989):291-2. PubMed ID: 20647458
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurements of red cell deformability and hydration reflect HbF and HbA
    Parrow NL; Tu H; Nichols J; Violet PC; Pittman CA; Fitzhugh C; Fleming RE; Mohandas N; Tisdale JF; Levine M
    Blood Cells Mol Dis; 2017 Jun; 65():41-50. PubMed ID: 28472705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype.
    Ngo D; Bae H; Steinberg MH; Sebastiani P; Solovieff N; Baldwin CT; Melista E; Safaya S; Farrer LA; Al-Suliman AM; Albuali WH; Al Bagshi MH; Naserullah Z; Akinsheye I; Gallagher P; Luo HY; Chui DH; Farrell JJ; Al-Ali AK; Alsultan A
    Blood Cells Mol Dis; 2013 Jun; 51(1):22-6. PubMed ID: 23465615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal hemoglobin in sickle cell anemia.
    Akinsheye I; Alsultan A; Solovieff N; Ngo D; Baldwin CT; Sebastiani P; Chui DH; Steinberg MH
    Blood; 2011 Jul; 118(1):19-27. PubMed ID: 21490337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease.
    Marcus SJ; Kinney TR; Schultz WH; O'Branski EE; Ware RE
    Am J Hematol; 1997 Jan; 54(1):40-6. PubMed ID: 8980259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic modifiers of homozygous sickle cell disease].
    Hartmann K; Kulozik AE
    Klin Padiatr; 2006; 218(3):170-3. PubMed ID: 16688674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic decline in fetal hemoglobin parameters in infants with sickle cell disease: implications for pharmacological intervention.
    Marcus SJ; Ware RE
    J Pediatr Hematol Oncol; 1999; 21(5):407-11. PubMed ID: 10524455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal hemoglobin in sickle cell anemia: a glass half full?
    Steinberg MH; Chui DH; Dover GJ; Sebastiani P; Alsultan A
    Blood; 2014 Jan; 123(4):481-5. PubMed ID: 24222332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil.
    Cardoso GL; Diniz IG; Silva AN; Cunha DA; Silva Junior JS; Uchôa CT; Santos SE; Trindade SM; Cardoso Mdo S; Guerreiro JF
    Blood Cells Mol Dis; 2014 Dec; 53(4):176-9. PubMed ID: 25084696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic studies of fetal hemoglobin in the Arab-Indian haplotype sickle cell-β(0) thalassemia.
    Alsultan A; Ngo D; Bae H; Sebastiani P; Baldwin CT; Melista E; Suliman AM; Albuali WH; Nasserullah Z; Luo HY; Chui DH; Steinberg MH; Al-Ali AK
    Am J Hematol; 2013 Jun; 88(6):531-2. PubMed ID: 23483609
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia.
    Quinn CT; Miller ST
    Hematol Oncol Clin North Am; 2004 Dec; 18(6):1339-54, ix. PubMed ID: 15511619
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Gardner K; Fulford T; Silver N; Rooks H; Angelis N; Allman M; Nkya S; Makani J; Howard J; Kesse-Adu R; Rees DC; Stuart-Smith S; Yeghen T; Awogbade M; Sangeda RZ; Mgaya J; Patel H; Newhouse S; Menzel S; Thein SL
    Blood Adv; 2018 Feb; 2(3):235-239. PubMed ID: 29437638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive, Ethnically Diverse Library of Sickle Cell Disease-Specific Induced Pluripotent Stem Cells.
    Park S; Gianotti-Sommer A; Molina-Estevez FJ; Vanuytsel K; Skvir N; Leung A; Rozelle SS; Shaikho EM; Weir I; Jiang Z; Luo HY; Chui DHK; Figueiredo MS; Alsultan A; Al-Ali A; Sebastiani P; Steinberg MH; Mostoslavsky G; Murphy GJ
    Stem Cell Reports; 2017 Apr; 8(4):1076-1085. PubMed ID: 28111279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Azacytidine increases fetal hemoglobin production in a patient with sickle cell disease.
    Dover GJ; Charache SH; Boyer SH; Talbot CC; Smith KD
    Prog Clin Biol Res; 1983; 134():475-88. PubMed ID: 6198661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increasing complexity of sickle cell anemia.
    Warth JA; Rucknagel DL
    Prog Hematol; 1983; 13():25-47. PubMed ID: 6199811
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction.
    Perumbeti A; Higashimoto T; Urbinati F; Franco R; Meiselman HJ; Witte D; Malik P
    Blood; 2009 Aug; 114(6):1174-85. PubMed ID: 19474450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.